Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • MRNA vs CLX✓SelectedUSD · CLXMRNA vs CLX performance historyLatest closeAs of-2.17%11/20
Stock and ETF performance explorer

MRNA vs CLX

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+147.0%
CLX return
-14.9%
Excess return
+161.9%
Maximum drawdown
-86.6%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 3y.

Portfolio and benchmark returns by period
PeriodPortfolioCLXExcessAlpha
1D-2.2%-0.2%-2.0%-2.1%
7D-12.7%-4.3%-8.4%-11.2%
30D-20.7%+25.3%-46.0%-27.8%
3M+46.3%+0.2%+46.1%+45.7%
6M+305.2%+14.0%+291.2%+295.7%
YTD+561.2%+9.1%+552.1%+543.4%
1Y+772.1%+10.0%+762.1%+746.5%
3Y+147.0%-13.9%+160.8%+187.9%
All+147.0%-14.9%+161.9%+187.9%

Cumulative growth

Daily Returns

Daily percentage return beside CLX.

Daily Out/Under-Performance

Portfolio return minus CLX return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × CLX return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 3y: compounded portfolio wealth divided by compounded CLX wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

3y analysis · Full analysis span regression · 6 months rolling